GC1118, an anti-EGFR monoclonal antibody, blocks irinotecan-induced EGFR activation and exhibits synergistic tumor regression in gastric cancer model

Autor:	Jae-Chul Lee, Hyung Jun Cho, Minkyu Hur, Yangmi Lim, Shi-Nai Lee, Eun Hee Lee, Jonghwa Won
Rok vydání:	2017
Předmět:	Oncology Irinotecan medicine.medical_specialty business.industry Internal medicine Cancer Model Tumor regression Medicine Hematology Anti-EGFR Monoclonal Antibody business medicine.drug
Zdroj:	Annals of Oncology. 28:iii135
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ab9aa8655355af400dc4e1e2c06d3ffb https://doi.org/10.1093/annonc/mdx261.378 Zobrazit plný text záznamu